Clinical Trials
10 trialsNCT01637766 2020-08-03
SIAC
Weill Medical College of Cornell University
Phase 1 Completed
NCT00326664 2016-03-07
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01158300 2015-05-04
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00107458 2014-08-07
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
Children's Oncology Group
Phase 1 Completed
NCT00946335 2014-07-09
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003141 2014-03-28
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
Children's Oncology Group
Phase 1 Completed
NCT01076530 2013-05-03
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00053963 2013-01-16
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00363272 2013-01-16
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00015899 2009-10-14
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed